Pharmaceuticals
10 Johnson & Johnson executives
These ten Johnson & Johnson executives have held CEO, CFO, executive vice president, chief officer and president roles at Johnson & Johnson and its Innovative Medicine and MedTech businesses. Readers can learn how Johnson & Johnson leaders run finance, research and development, procurement, medical affairs and commercial operations.
Professionals to explore
01—10Dominic Caruso
LinkedInExperience: CFO · Johnson & Johnson
Former CFO of Johnson & Johnson; the profile headline says retired, and lists the CFO role from 2007. The profile describes being the longest serving CFO in the company's history and leading its financial, operational and ethical performance for nearly two decades. Board member at Kyndryl since 2021 and at McKesson since 2018.
Jennifer Taubert
LinkedInExperience: Executive Vice President, Worldwide Chairman, Pharmaceuticals · Johnson & Johnson
Executive Vice President, Worldwide Chairman, Pharmaceuticals at Johnson & Johnson since July 2018; the profile headline names the role Worldwide Chairman, Innovative Medicine. Former Company Group Chairman for The Americas Pharmaceuticals (2015–2018) and North America Pharmaceuticals (2012–2015), and President, Internal Medicine, North America Pharmaceuticals (2009–2011).
Joaquin Duato
LinkedInExperience: Chairman of the Board and Chief Executive Officer · Johnson & Johnson
Chairman of the Board and Chief Executive Officer of Johnson & Johnson since January 2023, and Chief Executive Officer from January 2022. Former Vice Chairman of the Executive Committee (2018–2021), Executive Vice President, Worldwide Chairman, Pharmaceuticals (2011–2018) and Company Group Chairman, Diagnostics (2007–2009) at Johnson & Johnson.
John C. Reed
LinkedInExperience: Executive Vice President, Pharmaceuticals, Research & Development · Johnson & Johnson Innovative Medicine
Executive Vice President, Pharmaceuticals, Research & Development at Johnson & Johnson Innovative Medicine since April 2023. Former EVP, Global Head of R&D at Sanofi (2018–2023) and Global Head of Roche Pharma Research & Early Development (pRED) at Roche (2013–2018), giving a background in running large drug research organizations.
Joseph Wolk
LinkedInExperience: Executive Vice President, Chief Financial Officer · Johnson & Johnson
Executive Vice President, Chief Financial Officer of Johnson & Johnson since July 2018. Former Vice President, Investor Relations (2016–2018), CFO and Vice President, Finance for Global Pharmaceuticals (2014–2016) and Vice President, Finance for Medical Device Global Supply Chain (2010–2014) at Johnson & Johnson.
Julian Hooks
LinkedInExperience: Senior Vice President, Chief Procurement Officer · Johnson & Johnson
Senior Vice President, Chief Procurement Officer at Johnson & Johnson since January 2025. Former Senior Vice President, Global Services Procurement and Operations (2020–2024), and Chief Procurement Officer roles at Johnson & Johnson for the Corporate Tier (2017–2020), Consumer Companies (2011–2017) and Janssen EMEA Pharmaceutical Companies (2010–2011).
Mike D.
LinkedInExperience: Chief Medical Officer, Innovative Medicine · Johnson & Johnson
Chief Medical Officer, Innovative Medicine at Johnson & Johnson since March 2026. Former CMO and Executive VP, Medical Affairs and Pharmacovigilance at Bayer and a member of the executive committee of Bayer's pharma division (2014–2026), and Senior VP, Global Medical Affairs & Pharmacovigilance at Bayer (2007–2014). The profile describes a physician with expertise in medical safety science.
Namal Nawana
LinkedInExperience: Worldwide President, DePuy Synthes · Johnson & Johnson
Worldwide President, DePuy Synthes at Johnson & Johnson since October 2025, described as leading an orthopaedics-focused business with leading market share across major segments. Former Worldwide President DePuy Synthes Spine at Johnson & Johnson (2011–2012), Chairman and Founder of Sapphiros (2021–2025), and a director at Hologic (2018–2024).
Scott White
LinkedInExperience: Chief Operations Officer, NA Innovative Medicine · Johnson & Johnson Innovative Medicine
Chief Operations Officer, NA Innovative Medicine at Johnson & Johnson Innovative Medicine since November 2023, described as leading business operations including the Strategic Customer Group. Former Company Group Chairman North America Pharmaceuticals at Johnson & Johnson (2018–2023), and President, Immunology (2017–2018) and President, Oncology (2014–2017) at the Janssen Pharmaceutical Companies of Johnson & Johnson.
Tim Schmid
LinkedInExperience: Executive Vice President, Worldwide Chairman, MedTech, Johnson & Johnson · Johnson & Johnson MedTech
Executive Vice President, Worldwide Chairman, MedTech at Johnson & Johnson since October 2023, described as leading a $27B organization of 70,000+ employees. Former Company Group Chairman, Asia Pacific, MedTech (2018–2023), Chief Strategic Customer Officer, Medical Devices (2016–2018) and President, Ethicon U.S. (2012–2015) at Johnson & Johnson.
Choose the right perspective
Match the executive's business to your question, since a leader in Innovative Medicine sees different customers, regulators and pipelines than one in MedTech. Check each role's dates to confirm whether the experience you need is current or from an earlier period.
Questions to take into the conversation
- 01How does Johnson & Johnson decide where to invest across pharmaceuticals and medical technology?
- 02What do Johnson & Johnson procurement and operations leaders look for when choosing a new strategic supplier?
- 03How does a large healthcare company move a research program from early science to a commercial launch?
Reaching Johnson & Johnson executives
How can I contact one of these Johnson & Johnson executives?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 3 companies: Johnson & Johnson, Johnson & Johnson Innovative Medicine and Johnson & Johnson MedTech, based on profile data retrieved on October 8, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Johnson & Johnson executives?
You choose the offer, starting at $5 per person. It includes Instant Expert's 20% fee, so an offer that pays the person $100 costs you $125. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal